Overall survival benefit of osimertinib and clinical value of upfront cranial local therapy in untreated EGFR ‐mutant nonsmall cell lung cancer with brain metastasis-Reference-Cited by-全球学者库

Overall survival benefit of osimertinib and clinical value of upfront cranial local therapy in untreated EGFR ‐mutant nonsmall cell lung cancer with brain metastasis

Published:2022-01-06 Issue: Volume: Page:
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Intl Journal of Cancer

Author:

Zhao Yang¹²,Li Shuyan¹²³,Yang Xi¹²,Chu Li¹²,Wang Shengping²⁴,Tong Tong²⁴,Chu Xiao¹²,Yu Fan¹²,Zeng Ya¹²,Guo Tiantian¹²,Zhou Yue¹²,Zou Liqing¹²,Li Yida¹²,Ni Jianjiao¹²,Zhu Zhengfei¹²^ORCID

Affiliation:

1. Department of Radiation Oncology Fudan University Shanghai Cancer Center Shanghai China

2. Department of Oncology Shanghai Medical College, Fudan University Shanghai China

3. Department of Radiation Oncology Ruijin Hospital, Shanghai Jiaotong University School of Medicine Shanghai China

4. Department of Radiology Fudan University Shanghai Cancer Center Shanghai China

Funder

Science and Technology Commission of Shanghai Municipality

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.33904

Reference27 articles.

1. Brain metastases in adenocarcinoma of the lung: frequency, risk groups, and prognosis.

2. Incidence Proportions of Brain Metastases in Patients Diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System

3. Management of brain metastases in non-small cell lung cancer in the era of tyrosine kinase inhibitors

4. Preventing and treating brain metastases with three first‐line EGFR‐tyrosine kinase inhibitors in patients with EGFR mutation‐positive advanced non‐small cell lung cancer;Su PL;Ther Adv Med Oncol,2018

5. CNS Response to Osimertinib Versus Standard Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients With Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hirnmetastasen;Pneumologie;2024-01-24

2. Analysis of the efficacy of upfront brain radiotherapy versus deferred radiotherapy for EGFR/ALK-positive non-small cell lung cancer with brain metastases: a retrospective study;BMC Cancer;2024-01-23

3. Brain metastases and lung cancer: molecular biology, natural history, prediction of response and efficacy of immunotherapy;Frontiers in Immunology;2024-01-12

4. Measured Steps: Navigating the Path of Oligoprogressive Lung Cancer with Targeted and Immunotherapies;Current Oncology Reports;2024-01-02

5. Patterns of progression on first line osimertinib in patients with EGFR mutation-positive advanced non-small cell lung cancer (NSCLC): A Swiss cohort study;Lung Cancer;2024-01